Answers are grounded in this paper and cite their sources.
Background: Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) occurs in 1:5,000 births. It is a congenital disorder in the formation of the Müllerian ducts and therefore presents a primary amenorrhea, due to absence of vagina and uterus, with functional ovaries. Secondary sexual characteristics develop, having a normal female karyotype (46, XX). Women with the condition suffer from uterine factor infertility. The uterine factor is part of multifactorial infertility in 50% of cases; but, considered as the only responsible factor, its incidence is between 5-12%Objective: Report pediatric patient MRKH anomaly with description of management options.Case presentation: A 15-year-old female, Tanner IV breast development, absent vagina and with amenorrhea. Estradiol 56 pg/ml, FSH 5.7 mIU/ml, LH 10 mIU/ml, karyotype 46,XX. Pelvic ultrasound with ovaries present, uterine remains. Simple pelvic magnetic resonance: uterine remains, ovaries present, vaginal agenesis. Renal ultrasound and chest X-ray normal. Vaginoplasty surgery, removal of uterine remains. Current sexually active life is normal.Conclusion: The diagnosis of MRKH syndrome type 1 often occurs in late adolescence, when a young woman consults because she has not started her menstrual period. A diagnosis of MRKH Type 2 may be triggered by an absent period or a wide range of other symptoms or organ-related abnormalities, sometimes at an earlier age. There are surgical and non-surgical options for treating MRKH. Depending on your individual condition, you may benefit. These patients require comprehensive, interdisciplinary management to promote their full rehabilitation.
No takes yet. Share an insight, caveat, or question.
Gomez et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: